IC
INSM icon

Ikarian Capital’s Insmed INSM Stock Holding History

Ikarian Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,214
Closed -$689K – 167
2026
Q1 		$689K Sell
4,214
-5,123
-55% -$788K 0.06% 120
2025
Q4 		$1.63M Sell
9,337
-4,414
-32% -$805K 0.13% 111
2025
Q3 		$1.98M Sell
13,751
-150,000
-92% -$18.4M 0.2% 99
2025
Q2 		$16.5M Buy
163,751
+78,951
+93% +$6.04M 3.17% 7
2025
Q1 		$6.47M Sell
84,800
-35,000
-29% -$2.68M 0.8% 27
2024
Q4 		$8.27M Sell
119,800
-35,035
-23% -$2.52M 1.12% 20
2024
Q3 		$11.3M Buy
154,835
+107,000
+224% +$7.9M 1.58% 15
2024
Q2 		$3.2M Sell
47,835
-3,500
-7% -$136K 0.56% 43
2024
Q1 		$1.39M Buy
+51,335
New +$1.44M 0.15% 96
2023
Q4 		– Sell
-154,900
Closed -$4.02M – 154
2023
Q3 		$3.91M Sell
154,900
-330,100
-68% -$7.55M 0.47% 56
2023
Q2 		$10.2M Hold
485,000
– – 1.63% 20
2023
Q1 		$8.27M Buy
+485,000
New +$9.42M 1.88% 16
2022
Q3 		– Sell
-125,000
Closed -$3M – 134
2022
Q2 		$2.46M Buy
+125,000
New +$2.62M 0.45% 51
2020
Q3 		– Sell
-2,919
Closed -$80K – 195
2020
Q2 		$80K Sell
2,919
-170,000
-98% -$4.03M 0.01% 156
2020
Q1 		$2.77M Buy
+172,919
New +$4.1M 0.21% 83

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Ikarian Capital's INSM Position: Q2 2026 in Review

Ikarian Capital sold out of Insmed (INSM) in Q2 2026, closing a stake of 4,214 shares — an estimated $689K sold.

Ikarian Capital first reported a position in INSM in Q1 2020 and held it in 15 quarters. The position peaked at $16.5M in Q2 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Ikarian Capital reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Ikarian Capital sold 4,214 Insmed shares in Q2 2026, an estimated $689K.
  • Ikarian Capital first reported a position in Insmed in Q1 2020 and held it in 15 quarters.
  • Ikarian Capital's Insmed position peaked at $16.5M in Q2 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.